Novel soy germ pasta improves gastric emptying time

August 14, 2013
Novel soy germ pasta improves gastric emptying time
Pasta enriched with biologically active isoflavone aglycons significantly improves gastric emptying time in patients with type 2 diabetes, according to a pilot study published online July 8 in Diabetes Care.

(HealthDay)—Pasta enriched with biologically active isoflavone aglycons significantly improves gastric emptying time in patients with type 2 diabetes, according to a pilot study published online July 8 in Diabetes Care.

Kenneth D.R. Setchell, Ph.D., from Cincinnati Children's Hospital, and colleagues randomized 10 patients with delayed gastric emptying to consume one serving per day of soy germ pasta and conventional pasta for eight weeks, with a four-week washout. The [13C]octanoic acid breath test was used at baseline and after each period to measure gastric emptying time (t1/2). Blood glucose and insulin concentrations were determined after oral glucose load.

The researchers found that soy germ pasta significantly accelerated the t1/2 in these patients, from baseline to after treatment. This change is gastric emptying time was significantly accelerated compared to that for conventional pasta, without affecting glucose or insulin concentrations.

"These findings suggest that soy germ pasta may offer a simple dietary approach to managing diabetic gastropathy," the authors write.

Two authors disclosed to Aliveris, a manufacturer of soy germ pasta.

Explore further: In diabetes, gastric emptying remains stable over time

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

In diabetes, gastric emptying remains stable over time

August 24, 2012

(HealthDay)—Gastric emptying of solids and liquids and gastrointestinal symptoms remain stable over time in patients with long-term type 1 and type 2 diabetes, according to a study published online Aug. 13 in Diabetes Care.

Buspirone improves symptoms in functional dyspepsia

October 29, 2012

(HealthDay)—Buspirone, a 5-hydroxytryptamine 1A receptor agonist, improves symptom severity in patients with functional dyspepsia (FD), according to a proof-of-concept study published in the November issue of Clinical Gastroenterology ...

Pramlintide improves glucose control in type 1 diabetes

July 25, 2012

(HealthDay) -- The addition of pramlintide, an analog of the naturally-occurring β-cell peptide amylin, before meals improves blood glucose control in patients with type 1 diabetes receiving insulin through an external ...

Sucralose affects response to oral glucose load in obese

July 2, 2013

(HealthDay)—For obese adults who do not use non-nutritive sweetener (NNS), sucralose affects the glycemic and insulin responses to an oral glucose load, according to a study published online April 30 in Diabetes Care.

Bile acid sequestrant reduces glucose concentration in T2DM

January 30, 2013

(HealthDay)—For patients with type 2 diabetes taking metformin monotherapy, the bile acid sequestrant colesevelam reduces fasting and postprandial glucose concentrations without any effects on insulin concentration, secretion, ...

Recommended for you

New blood test may better predict gestational diabetes

April 27, 2017

A new study led by researchers at Brigham and Women's Hospital has found that a single measurement of plasma glycated CD59 (GCD59), a novel biomarker for diabetes, at weeks 24-28 of gestation identified, with high sensitivity ...

Post-biotics may help shield obese from diabetes

April 20, 2017

You've heard of pre-biotics and pro-biotics, but now you'll be hearing a lot more about post-biotics. Researchers at McMaster University have begun to identify how post-biotics, or the by-products of bacteria, lower blood ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.